For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
CRISPR-Cas9 engineered knockout cell lines are helping scientists across the globe to break new boundaries within life science. From validating biotech targets to accelerating the clinical pipeline, CRISPR knock-out cell lines are providing the analytical power to ask new questions, drive new avenues of proteomic research and provide answers that are driving medicine forward.
Here we have collated some of the most recent key CRISPR knock-out cell line publications, showing how these CRISPR knock-out cell lines are currently being used to push the bounds of biomedical research.
Yan Y, Zhou B, Qian C, et al. bioRxiv. (2020) doi: https://doi.org/10.1101/2020.05.14.096867
CRISPR knockout HEK293T cells negative for RIPK2, MAP2K7, and PRKDC were used in this study to demonstrate the potential of RIPK2 as an actionable drug target for the personalized treatment of advanced prostate cancer, by preventing the activation of the MKK7/JNK/c-Myc phosphorylation pathway and promoting the degradation of c-Myc.
Brack E, Wachtel M, Wolf A, et al. Cell Death Differ. (2020) 27(8):2500-2516
CRISPR knock-out cell lines negative for a large dynamin GTPase helped determine a new form of dynamin-dependent programmed cell death mediated through the production of reactive oxygen species by treatment with fenretinide, the drug used for treating childhood sarcomas.
Uzunparmak B, Gao M, Lindemann A, et al. bioRxiv (2020) https://doi.org/10.1101/2020.04.17.039040
A CRISPR knock-out murine oral squamous cell carcinoma cell line negative for Caspase-8 was used to promote the understanding of the effects of mutations in this gene in head and neck squamous cell carcinoma (HNSCC). CASP8 is shown to regulate necroptosis in HSNCC with the potential to therapeutically exploit this pathway.
Haidar M, Asselbergh B, Adriaenssens E, et al. Autophagy. (2019) 15(6):1051-1068
Using HSPB1-/- CRISPR knockout HeLa cells this paper indicates that the molecular chaperone HSPB1 serves a regulatory role in autophagy via interaction with the SQSTM1/p62 autophagy receptor and show links with peripheral neuropathy in patient-derived motor neurons.
Yu Y, Zielinska M, Li W, Bernkopf DB, et al. Sci Rep. (2020) 20;10(1):8323
PGAM5-/- CRISPR knock-out HeLa cells are used to demonstrate the role of PGAM5 in the regulation of IFNß in response to viral infection, as part of the innate immune system.